HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?

Key Takeaways DGX has risen 25.7% YTD, outpacing its peer as the diagnostics market continues to expand.HOLX sees growth in Breast Health, GYN Surgical and Molecular Diagnostics across key global markets.DGX gains from advanced diagnostics demand, strategic acquisitions and its Invigorate cost-saving program.In the fast-growing diagnostics testing market, Hologic (HOLX) and Quest Diagnostics (DGX) stand out as two prominent players, each with its own niche. Hologic focuses on women’s health, providing a wid ...